SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
Vertex announces global regulatory submissions for sickle cell disease and beta thalassemia
Vertex receives FDA approval for one of our CF medicines in children with cystic fibrosis ages 12 to <24 months
Our investigational pain medicine advances into pivotal development for acute pain and receives U.S. FDA Breakthrough Therapy Designation
Vertex announces that the U.S. FDA has lifted the clinical hold on the Phase 1/2 clinical trial for the potential treatment of type 1 diabetes
Vertex and CRISPR Tx present new data at EHA 2022 on investigational gene-edited therapy for the treatment of sickle cell...
Working at Vertex
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Featured Stories
Derya Balata and Teame Araya are Vertex’s newest Science Leaders Scholars. Learn more about these two outstanding students who have been selected to receive a four-year, full scholarship to pursue a STEM-related course of study at the University of Massachusetts.
September is Pain Awareness Month in the U.S., dedicated to raising public awareness around pain, pain management and the work that pain professionals do every day. Hear from Vice President Jim Jones on why his career led him to clinical development for our pain program.
This September, join us in recognizing Duchenne Action Month by learning from some of our female scientists working on Duchenne muscular dystrophy (DMD). These scientists are passionate about their research and raising awareness for DMD.
Derya Balata and Teame Araya are Vertex’s newest Science Leaders Scholars. Learn more about these two outstanding students who have been selected to receive a four-year, full scholarship to pursue a STEM-related course of study at the University of Massachusetts.
September is Pain Awareness Month in the U.S., dedicated to raising public awareness around pain, pain management and the work that pain professionals do every day. Hear from Vice President Jim Jones on why his career led him to clinical development for our pain program.
This September, join us in recognizing Duchenne Action Month by learning from some of our female scientists working on Duchenne muscular dystrophy (DMD). These scientists are passionate about their research and raising awareness for DMD.
